Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria E Suarez-Almazor

Showing results (21-30 of 243) with videos related to

Pageof 25
Sort By:
British Medical Bulletin|March 5, 2010
New understanding and approaches to treatment in rheumatoid arthritisJean H Tayar, Maria E Suarez-Almazor
Rheumatology (Oxford, England)|December 10, 2019
Frequency and distribution of various rheumatic disorders associated with checkpoint inhibitor therapyNoha Abdel-Wahab, Maria E Suarez-Almazor
Arthritis & Rheumatology (Hoboken, N.J.)|August 6, 2019
Is Immune Checkpoint Inhibitor Treatment an Option for Patients With Rheumatic Diseases and Cancer?Lenore M Buckley, Maria E Suarez-Almazor
Current Rheumatology Reports|July 18, 2012
Lipid paradox in rheumatoid arthritis: changes with rheumatoid arthritis therapiesMatxalen Amezaga Urruela, Maria E Suarez-Almazor
Current Rheumatology Reports|October 12, 2012
Acupuncture in the treatment of rheumatic diseasesMatxalen Amezaga Urruela, Maria E Suarez-Almazor
Rheumatic Diseases Clinics of North America|April 7, 2019
Digital Patient Education and Decision AidsMaria A Lopez-Olivo, Maria E Suarez-Almazor
Rheumatic Diseases Clinics of North America|April 26, 2024
Immune Checkpoint Inhibitor-induced MyositisAthira Jayan, Andrew L Mammen, Maria E Suarez-Almazor
Advances in Experimental Medicine and Biology|March 22, 2017
Adverse Events in Cancer ImmunotherapyNoha Abdel-Wahab, Anas Alshawa, Maria E Suarez-Almazor
Rheumatic Diseases Clinics of North America|November 15, 2011
Neoplastic and paraneoplastic synovitisMaria F Marengo, Maria E Suarez-Almazor, Huifang Lu
Current Opinion in Rheumatology|March 15, 2019
Arthritis risk with immune checkpoint inhibitor therapy for cancerXerxes Pundole, Noha Abdel-Wahab, Maria E Suarez-Almazor
Pageof 25

Showing results (21-30 of 243) with videos related to

Sort By:
Pageof 25
British Medical Bulletin|March 5, 2010
New understanding and approaches to treatment in rheumatoid arthritisJean H Tayar, Maria E Suarez-Almazor
Rheumatology (Oxford, England)|December 10, 2019
Frequency and distribution of various rheumatic disorders associated with checkpoint inhibitor therapyNoha Abdel-Wahab, Maria E Suarez-Almazor
Arthritis & Rheumatology (Hoboken, N.J.)|August 6, 2019
Is Immune Checkpoint Inhibitor Treatment an Option for Patients With Rheumatic Diseases and Cancer?Lenore M Buckley, Maria E Suarez-Almazor
Current Rheumatology Reports|July 18, 2012
Lipid paradox in rheumatoid arthritis: changes with rheumatoid arthritis therapiesMatxalen Amezaga Urruela, Maria E Suarez-Almazor
Current Rheumatology Reports|October 12, 2012
Acupuncture in the treatment of rheumatic diseasesMatxalen Amezaga Urruela, Maria E Suarez-Almazor
Rheumatic Diseases Clinics of North America|April 7, 2019
Digital Patient Education and Decision AidsMaria A Lopez-Olivo, Maria E Suarez-Almazor
Rheumatic Diseases Clinics of North America|April 26, 2024
Immune Checkpoint Inhibitor-induced MyositisAthira Jayan, Andrew L Mammen, Maria E Suarez-Almazor
Advances in Experimental Medicine and Biology|March 22, 2017
Adverse Events in Cancer ImmunotherapyNoha Abdel-Wahab, Anas Alshawa, Maria E Suarez-Almazor
Rheumatic Diseases Clinics of North America|November 15, 2011
Neoplastic and paraneoplastic synovitisMaria F Marengo, Maria E Suarez-Almazor, Huifang Lu
Current Opinion in Rheumatology|March 15, 2019
Arthritis risk with immune checkpoint inhibitor therapy for cancerXerxes Pundole, Noha Abdel-Wahab, Maria E Suarez-Almazor
Pageof 25